By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Gottfried-Hagen-Str. 62

Koln    D-51105  Germany
Phone: 49-0-2-21-46-020800 Fax: 49-0-2-21-46-020801


Company News
CEVEC And Beckman Research Institute Of City of Hope Enter Into A Cooperation And License Agreement On CEVEC's Proprietary CAP(R)GT Technology 1/20/2016 9:21:02 AM
CEVEC Strengthens Team To Execute Rapid Growth Strategy 10/14/2015 10:19:59 AM
CEVEC And CellGenix GmbH Sign Collaboration And License Agreement For CEVEC's Proprietary CAP Go Technology 10/7/2015 10:51:14 AM
CEVEC Introduces CAP(R)GT Cell-Expression System For Scalable Viral Gene Therapy Vector Production 9/8/2015 9:31:59 AM
CEVEC Raises EUR 4.5 Million In A Financing Round To Commercialize Its Leading CAP Based Technologies 7/22/2015 2:21:35 PM
CEVEC Announces Appointment Of Life Sciences Industry Expert Frank Ubags As Chief Executive Officer 4/17/2015 9:00:18 AM
CEVEC: CAP® Derived Recombinant C1 Inhibitor Matches Berinert® In Animal Study 2/2/2015 10:01:31 AM
CEVEC Appoints New Management Team 9/22/2014 6:34:19 AM
CEVEC and Catalent Pharma Solutions Offer Joint Cell Line Development Service 6/16/2011 10:50:47 AM
Aragen Bioscience, Inc. and CEVEC Sign License Agreement for Human CAP(R) and CAP-T(TM) Technology 4/30/2010 1:46:47 PM